Tech Center 1600 • Art Units: 1614 1629 1652
This examiner grants 83% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17790594 | METHODS OF USING ANDROGRAPHOLIDE, ORIDONIN AND ISOLIQUIRITIGENIN AND DERIVATIVES THEREOF | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 19329494 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19329476 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19328077 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19324046 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19315454 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19315441 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19308124 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19303300 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19267447 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19267464 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19260035 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19258817 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19245208 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19242858 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19241304 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19236933 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19230054 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19230051 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19230047 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19215216 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 19215242 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Final Rejection | Veradermics, Incorporated |
| 19094703 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Non-Final OA | Veradermics, Incorporated |
| 18419878 | VIRAL PROPHYLAXIS TREATMENT METHODS AND PRE-EXPOSURE PROPHYLAXIS KITS | Non-Final OA | ELIAN LLC |
| 18495512 | FIBROTIC TREATMENT | Final Rejection | Monash University |
| 18549916 | NASAL COMPOSITIONS COMPRISING ALCAFTADINE | Non-Final OA | ALKEM LABORATORIES LIMITED |
| 17639578 | PHARMACEUTICAL COMPOSITION COMPRISING MITOTANE ADMINISTERED ORALLY FOR TREATMENT OF ADRENOCORTICAL CARCINOMA AND CUSHING'S SYNDROME | Non-Final OA | Mohamed SKIBA |
| 18227719 | BIOSYNTHESIS OF SUBSTITUTED COMPOUNDS AND CANNABINOIDS | Non-Final OA | Invizyne Technologies, Inc. |
| 18227808 | PPARAXANTHINE-BASED COMPOSITIONS FOR INHIBITING INFLAMMATION, IMPROVING JOINT HEALTH, AND ENHANCING IMMUNE FUNCTION | Non-Final OA | PX ING, LLC |
| 17555763 | Delivery System For Ayahuasca-Like Substances | Non-Final OA | Monster Color Carnival LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy